SEC Comment Letter 0000000000-26-000285 to CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC.
Date: Jan. 9, 2026 · CIK: 0001851484 · Accession: 0000000000-26-000285
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292577
Letter
January 9, 2026 Leonard Mazur Chief Executive Officer Citius Oncology, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 Re:Citius Oncology, Inc. Registration Statement on Form S-3 Filed January 5, 2026 File No. 333-292577 Dear Leonard Mazur: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Christopher Agoranos
Show Raw Text
January 9, 2026
Leonard Mazur
Chief Executive Officer
Citius Oncology, Inc.
11 Commerce Drive, First Floor
Cranford, NJ 07016
Re:Citius Oncology, Inc.
Registration Statement on Form S-3
Filed January 5, 2026
File No. 333-292577
Dear Leonard Mazur:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Christopher Agoranos